BIT225 trial did not fail.It was not expected to improve reduction in HIV in the blood over existing ART.
It was tested to see effect against HIV in macrophages and successful against HIV in those reservoirs.
Siginificant outcome.
Excellent safety and well tolerated by HIV subjects.
More beneficial outcome to patients with BIT225 in combination with ART.
Doesn't sound like a failure to me.
So I hold BIT and will hold.
- Forums
- ASX - By Stock
- BIT
- Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data, page-638
-
-
- There are more pages in this discussion • 401 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $24.36M |
Open | High | Low | Value | Volume |
2.5¢ | 2.6¢ | 2.5¢ | $7.699K | 307.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 54557 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 194760 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 54557 | 0.026 |
8 | 664000 | 0.025 |
2 | 3373333 | 0.024 |
2 | 153913 | 0.023 |
3 | 625000 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 194760 | 1 |
0.028 | 400000 | 2 |
0.029 | 305600 | 3 |
0.030 | 97636 | 3 |
0.031 | 109129 | 2 |
Last trade - 12.36pm 21/08/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online